Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer

NCT06449989 is registered in ClinicalTrials.gov with Blokhin's Russian Cancer Research Center as lead sponsor.

NCT NCT06449989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06449989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer
Lead sponsor
Blokhin's Russian Cancer Research Center
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2024
Completion date
September 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

braf gene mutation, brain metastases, adult, colorectal cancer metastatic, her2 gene mutation, msi, ras (kras or nras) gene mutation